This course counts toward the following majors: Health Enterprise Management, Health Industry Management

Although this course is intended primarily for first-year students majoring in health industry management, all students with an interest in this sector are encouraged to enroll. It is particularly useful for students interested in pharmaceuticals, biotechnology and medical devices, who need to understand not only how their sector fits into the industry but also how their customers are paid and how they use their products. The course introduces students to the key issues confronting the major participants in the U.S. health system (suppliers, providers and payers). Topics covered include a framework for evaluating healthcare systems, understanding the demand for healthcare products and services, technology assessment, managed care systems, cost/quality issues and payment mechanisms.

Biotech Business Practicum (formerly BIOT-913-0) (HEMA-913-0)

This course counts toward the following majors: Biotechnology Management, Health Enterprise Management

Biotechnology demands depth of knowledge and hands-on experience from its managers. Biotech Business Practicum gives you an opportunity to apply the theoretical concepts you learned in class with the real, practical needs of the biotechnology firm. Students, individually or as part of a team, work on a project for a biotech, pharmaceutical, medical device or venture capital concern under the mentorship of a Kellogg faculty member and an industrial mentor.

Medical Innovation I (HEMA-915-0)

This course counts toward the following majors: Biotechnology Management, Health Enterprise Management,

Medical Innovation is a two-quarter sequence focused on the creation of innovations for the health industry. Students, guided by faculty and physicians from Kellogg and the Northwestern law, medical and engineering schools work in teams to develop medical products. Students experience the entire innovation life cycle from ideation to prototyping, legal protection, market sizing and business plan development. At the end of the course, the teams present their business plans to a panel of venture capitalists with the goal of securing funding and possible formation of a start-up. Key deliverables in this class include: “elevator pitch” to request prototype/pilot funding, prototype development, provisional patent application, FDA 510/K application and business plan presentation to venture capitalists. To enroll in this course, permission from the instructor is required before registration. Students must take both the fall (I) and winter (II) quarter courses, in sequence, and will earn 2.0 credits after successfully completing both courses.

Medical Innovation II: Developing Biomedical Products from Patient to Market (formerly BIOT-916-0) (HEMA-916-0)

This course counts toward the following majors: Biotechnology Management, Health Enterprise Management

Medical Innovation is a two-quarter sequence focused on the creation of innovations for the health industry. Students, guided by faculty and physicians from Kellogg and the Northwestern law, medical and engineering schools work in teams to develop medical products. Students experience the entire innovation life cycle from ideation to prototyping, legal protection, market sizing and business plan development. At the end of the course, the teams present their business plans to a panel of venture capitalists with the goal of securing funding and possible formation of a start-up. Key deliverables in this class include: “elevator pitch” to request prototype/pilot funding, prototype development, provisional patent application, FDA 510/K application and business plan presentation to venture capitalists. To enroll in this course, permission from the instructor is required before registration. Students must take both the fall and winter quarter courses, in sequence, and will earn 2.0 credits after successfully completing both courses.